200 related articles for article (PubMed ID: 7744150)
1. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group.
Aso Y; Akaza H; Kotake T; Tsukamoto T; Imai K; Naito S
Eur Urol; 1995; 27(2):104-9. PubMed ID: 7744150
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group.
Aso Y; Akazan H
Urol Int; 1992; 49(3):125-9. PubMed ID: 1466089
[TBL] [Abstract][Full Text] [Related]
3. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer.
Naito S; Koga H; Yamaguchi A; Fujimoto N; Hasui Y; Kuramoto H; Iguchi A; Kinukawa N;
J Urol; 2008 Feb; 179(2):485-90. PubMed ID: 18076918
[TBL] [Abstract][Full Text] [Related]
4. New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrence.
Akaza H
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():253-6. PubMed ID: 9210905
[TBL] [Abstract][Full Text] [Related]
5. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
Hinotsu S; Akaza H; Ohashi Y; Kotake T
Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
[TBL] [Abstract][Full Text] [Related]
6. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
Messing E; Kim KM; Sharkey F; Schultz M; Parnes H; Kim D; Saltzstein D; Wilding G
J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
[TBL] [Abstract][Full Text] [Related]
7. Comment on "Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?".
Naito S
Nat Clin Pract Urol; 2009 Mar; 6(3):E5. PubMed ID: 19265853
[No Abstract] [Full Text] [Related]
8. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial.
Alfthan O; Tarkkanen J; Gröhn P; Heinonen E; Pyrhönen S; Säilä K
Eur Urol; 1983; 9(1):6-9. PubMed ID: 6337054
[TBL] [Abstract][Full Text] [Related]
9. The role of adjunctive immunotherapy in superficial bladder cancer.
Fujita K
Cancer; 1987 Jun; 59(12):2027-30. PubMed ID: 3567865
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic oral UFT therapy for superficial bladder cancer.
Kubota Y; Hosaka M; Fukushima S; Kondo I
Cancer; 1993 Mar; 71(5):1842-5. PubMed ID: 8448746
[TBL] [Abstract][Full Text] [Related]
11. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III.
Rajala P; Liukkonen T; Raitanen M; Rintala E; Kaasinen E; Helle M; Lukkarinen O
J Urol; 1999 Apr; 161(4):1133-5; discussion 1135-6. PubMed ID: 10081854
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
Boccardo F; Cannata D; Rubagotti A; Guarneri D; Decensi A; Canobbio L; Curotto A; Martorana G; Pegoraro C; Selvaggi F
J Clin Oncol; 1994 Jan; 12(1):7-13. PubMed ID: 8270987
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic treatment of superficial bladder tumor.
Lee C; Park MS
Int J Urol; 1998 Nov; 5(6):511-20. PubMed ID: 9855117
[No Abstract] [Full Text] [Related]
14. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors.
Rodrigues Netto Júnior N; Lemos GC
J Urol; 1983 Jan; 129(1):33-4. PubMed ID: 6402610
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group.
Newling DW; Robinson MR; Smith PH; Byar D; Lockwood R; Stevens I; De Pauw M; Sylvester R
Eur Urol; 1995; 27(2):110-6. PubMed ID: 7744151
[TBL] [Abstract][Full Text] [Related]
16. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
[TBL] [Abstract][Full Text] [Related]
17. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group.
Raitanen MP; Lukkarinen O
Br J Urol; 1995 Dec; 76(6):697-701. PubMed ID: 8535711
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
[TBL] [Abstract][Full Text] [Related]
20. Very Long-Term Treatment with a
Mutoh M; Yoshimura K; Fujii G; Nakamura T; Takeshita T; Wakabayashi K; Sakai T; Ishikawa H
Nutrients; 2020 May; 12(6):. PubMed ID: 32485893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
